No Prescription |
 |
 | ||
|
TMP Proloprim |
|
| ||
No Prescription » Prescription Drugs 16 » TMP Proloprim IndicationsTMP Tablets are indicated:for the treatment of acute urinary tract infections;for long term prophylaxis of recurrent or suppression of chronic urinary tract infections following sterilisation of the urine.Dosage and AdministrationThis product is not able to deliver all approved dose regimensAcute urinary tract infections:Adults and children over 12 years: 300 mg once dailyChildren aged 6 to 12 years: 150 mg once dailyChildren aged 6 months to 5 years: 75 mg once dailyChildren aged 6 weeks to 5 months: 40 mg once dailyThis dosage approximates to 6 mg/kg bodyweight/day. The recommended duration of treatment will vary according to medical practice in different countries.Long term prophylaxis of recurrent or suppression of chronic urinary tract infections following sterilisation of the urine:Adults and children over 12 years: 100 mg once dailyChildren aged 6 to 12 years: 50 mg once dailyChildren aged 6 months to 5 years: 25 mg once dailyThis dosage approximates to 2 mg/kg bodyweight/day.Treatment may be continued for 3 to 12 months or more as appropriate.It may be preferable to take TMP beofre retiring to bed with some food or drink which will minimise the possibility of gastrointestinal disturbances.Dosage recommendations for patients with impaired renal function:When a patient is known to have a creatinine clearance below 15 to 20 ml/minute trimethoprim plasma levels should be monitored after approximately 3 days treatment. When clearance is below 10 ml/minute TMP should not be administered unless plasma concentrations can be estimated regularly and haemodialysis facilities are available. Buy TMP Proloprim and other Prescription Drugs 16 products online at Medstore. Buy Online at Medstore - Click Here!
About TMP Proloprim: Product Type: Prescription Drugs 16 TMP ( Proloprim Trimpex Generic Trimethoprim ) TMP (Proloprim Trimpex Generic Trimethoprim) Proloprim Trimpex Generic Trimethoprim 300mg Proloprim Trimpex Generic Trimethoprim TMP
View more Prescription Drugs 16 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
